bioRxivCancer BiologyPreprint
Optimizing chemo-scheduling based on tumor growth rates
Abstract
We review the classic tumor growth and regression laws of Skipper and Schable based on fixed exponential growth assumptions, and Norton and Simons law based on a Gompertzian growth assumption. We then discuss ways to optimize chemotherapeutic scheduling using a Moran process evolutionary game-theory model of tumor growth that incorporates more general dynamical and evolutionary features of tumor cell kinetics. Using this model, and employing the quantitative notion of Shannon entropy which assigns high values to low-dose metronomic (LDM) therapies, and low values to maximum tolerated dose (MTD) therapies, we show that low-dose metronomic strategies can outperform maximum tolerated dose strategies, particularly for faster growing tumors. The general concept of designing different chemotherapeutic strategies for tumors with different growth characteristics is discussed.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chemotherapeutic dose scheduling based on tumor growth rates: the case for low dose metronomic high entropy therapies
J. West, P. K. Newton·bioRxiv·Jul 19, 2017
- On the design of treatment schedules that avoid chemotherapeutic resistance
Y. Ma, P.K. Newton·bioRxiv·May 17, 2018
- Optimal Chemotherapy Scheduling for Non-Genetic Drug Resistance
Sasan Paryad-Zanjani, Michael Saint-Antoine, Abhyudai Singh·bioRxiv·May 11, 2021
- Delicate balances in cancer chemotherapy: modeling immune recruitment and emergence of systemic drug resistance
Anh Phong Tran, M. Ali Al-Radhawi, … Eduardo D. Sontag·Frontiers in ImmunologyPeer-reviewed·Jun 30, 2020
- Chemotherapy dose scheduling via Q-learning in a Markov tumor model
M. Giles, Paul K. Newton·bioRxiv·Jun 5, 2025
- Second-order effects of chemotherapy pharmacodynamics and pharmacokinetics on tumor regression and cachexia
L. Pierik, P. McDonald, … J. West·bioRxiv·Jun 14, 2023